Atlas FDA

Optune®

FDA premarket approval P100034/S040 · decided 2025-06-06

Approval details

PMA number
P100034
Supplement
S040
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Optune®
Generic name
Stimulator, low electric field, tumor treatment
Applicant
Novocure, GmbH
Date received
2025-05-08
Decision date
2025-06-06
Days to decision
29 days
Decision code
OK30
Product code
NZK
Advisory committee
Neurology
Expedited review
No
Location
Baar
Statement
the implementation of a second-source supplier of Li-Ion battery cells

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.